| Document and Entity Information | Feb. 28, 2023 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001593899 |
| Document Type | 8-K |
| Document Period End Date | Feb. 28, 2023 |
| Entity Registrant Name | Atea Pharmaceuticals, Inc. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-39661 |
| Entity Tax Identification Number | 46-0574869 |
| Entity Address, Address Line One | 225 Franklin Street |
| Entity Address, Address Line Two | Suite 2100 |
| Entity Address, City or Town | Boston |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02110 |
| City Area Code | (857) |
| Local Phone Number | 284-8891 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.001 par value per share |
| Trading Symbol | AVIR |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
